Keywords: AstraZeneca, Crestor, FDA, Indications, Heart attack, Stroke, Cancer metabolism drug research, Cancer Resarch UK

AstraZeneca gets wider US indications for Crestor; enters cancer drug development deal with UK charity

Article | 09 February 2010

The US Food and Drug Administration yesterday approved Anglo-Swedish drug major AstraZeneca’s blockbuster cholesterol-lowerer Crestor (rosuvastatin calcium) for additional ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in